BioXcel Therapeutics Inc (BTAI)
2.07
-0.02
(-0.96%)
USD |
NASDAQ |
May 17, 16:00
2.07
0.00 (0.00%)
After-Hours: 20:00
BioXcel Therapeutics 1 Year Total Returns (Daily): -92.29% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
May 17, 2024 | -92.29% |
May 16, 2024 | -92.41% |
May 15, 2024 | -92.43% |
May 14, 2024 | -92.25% |
May 13, 2024 | -92.05% |
May 10, 2024 | -92.69% |
May 09, 2024 | -91.54% |
May 08, 2024 | -91.95% |
May 07, 2024 | -89.86% |
May 06, 2024 | -89.17% |
May 03, 2024 | -88.49% |
May 02, 2024 | -87.69% |
May 01, 2024 | -87.79% |
April 30, 2024 | -87.78% |
April 29, 2024 | -87.49% |
April 26, 2024 | -87.45% |
April 25, 2024 | -87.57% |
April 24, 2024 | -88.17% |
April 23, 2024 | -86.60% |
April 22, 2024 | -87.14% |
April 19, 2024 | -86.94% |
April 18, 2024 | -87.95% |
April 17, 2024 | -87.94% |
April 16, 2024 | -85.70% |
April 15, 2024 | -85.33% |
Date | Value |
---|---|
April 12, 2024 | -82.62% |
April 11, 2024 | -83.92% |
April 10, 2024 | -84.81% |
April 09, 2024 | -85.13% |
April 08, 2024 | -84.78% |
April 05, 2024 | -84.41% |
April 04, 2024 | -85.46% |
April 03, 2024 | -86.18% |
April 02, 2024 | -85.85% |
April 01, 2024 | -84.89% |
March 28, 2024 | -84.07% |
March 27, 2024 | -83.89% |
March 26, 2024 | -84.39% |
March 25, 2024 | -84.44% |
March 22, 2024 | -84.24% |
March 21, 2024 | -85.38% |
March 20, 2024 | -85.26% |
March 19, 2024 | -85.99% |
March 18, 2024 | -85.89% |
March 15, 2024 | -86.33% |
March 14, 2024 | -85.88% |
March 13, 2024 | -86.64% |
March 12, 2024 | -86.59% |
March 11, 2024 | -85.96% |
March 08, 2024 | -89.00% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-94.11%
Minimum
Feb 12 2024
1.28K%
Maximum
Nov 11 2020
66.81%
Average
-20.89%
Median
May 06 2021
1 Year Total Returns (Daily) Benchmarks
Cormedix Inc | 17.03% |
Amicus Therapeutics Inc | -14.09% |
Insmed Inc | 33.46% |
Altimmune Inc | 74.13% |
InfuSystems Holdings Inc | -29.85% |